COVID, Quickly, Episode 3: Vaccine Inequality—plus Your Body the Variant Fighter

COVID, Quickly, Episode 3: Vaccine Inequality—plus Your Body the Variant Fighter

Tanya Lewis: Hi, and welcome to COVID, Quickly, a new Scientific American podcast series! Many Black and Latino households are less likely to have high-speed Internet and the time to spend online booking vaccine appointments. Why is there so much controversy over the AstraZeneca vaccine? Earlier this week, the company put out a press release saying the vaccine was 78 percent effective at preventing COVID in a U.S. trial. Fischman: Come back in two weeks for the next episode of COVID, Quickly!

About Us

When you want to outsmart the world, you turn to the facts. And the facts are in the science.

Subscribe to our newsletter!